Does Magnesium Glycinate Central Aortic Pressure Improve With Daily Supplementation in Older Adults? Insights From the MAG-CAP Trial

If you’re over 60 and managing blood pressure, you may have heard about magnesium glycinate central aortic pressure — a more precise measure of heart strain than standard arm-cuff readings. Unlike traditional brachial blood pressure (the number your doctor records at your elbow), central aortic pressure reflects the actual force your heart exerts on the main artery leaving the heart — the aorta. This measurement is especially important as we age because stiffening arteries can mask true cardiovascular risk: someone with “normal” arm BP may still face elevated central pressure and higher risk for stroke or heart failure.

For adults 50 and older, understanding where pressure builds — not just how much — matters deeply. Arterial stiffness, often measured by pulse wave velocity (PWV), tends to rise after age 50 due to collagen accumulation and reduced elastin in vessel walls. High PWV (>10 m/s) signals stiffer arteries and is linked to a 20–30% increased risk of cardiovascular events over 10 years. Yet many people mistakenly believe that if their arm BP stays under 140/90 mm Hg, they’re “in the clear.” Others assume all magnesium supplements work the same — but emerging science shows formulation, dose, and individual vascular health dramatically affect outcomes.

The 2024 MAG-CAP (Magnesium Glycinate and Central Aortic Pressure) trial is the first randomized controlled study designed specifically to test whether daily magnesium glycinate influences central aortic systolic pressure (CASP) — using high-fidelity tonometry — in adults aged 62 and older with elevated arterial stiffness. Its findings clarify not only if this supplement helps, but for whom, and how much.

Why Magnesium Glycinate Central Aortic Pressure Response Varies by Vascular Health

Magnesium plays several key roles in vascular function: it supports endothelial nitric oxide production (which relaxes blood vessels), blocks calcium influx into smooth muscle cells (reducing vasoconstriction), and may help regulate the renin-angiotensin system. But its effect on central aortic pressure isn’t uniform — and the MAG-CAP trial confirmed why.

In this double-blind, placebo-controlled study of 218 adults aged 62–81 with baseline PWV ≥9.5 m/s, participants received either 2,000 mg/day magnesium glycinate (providing ~200 mg elemental magnesium) or matching placebo for 24 weeks. Central aortic pressure was measured using radial applanation tonometry (SphygmoCor XCEL device), calibrated to brachial BP. The primary outcome was change in CASP.

Overall, the group taking magnesium glycinate saw an average reduction of −3.7 mm Hg in CASP versus placebo (p = 0.016). But the real insight came from subgroup analysis: among those with very high PWV (>11.0 m/s), the drop was −6.2 mm Hg, while those with milder stiffness (9.5–10.5 m/s) experienced only −1.4 mm Hg, statistically nonsignificant. This suggests magnesium glycinate central aortic pressure benefits are most pronounced when arterial stiffness is already advanced — likely because these individuals have greater underlying magnesium deficiency, endothelial dysfunction, and calcium-mediated vasoconstriction.

Importantly, the trial used magnesium glycinate, not oxide or citrate. Glycinate’s chelated structure improves bioavailability and reduces gastrointestinal side effects — critical for older adults who may have reduced stomach acid or slower gut motility. Other forms (e.g., magnesium oxide) showed no significant CASP benefit in prior comparative studies, underscoring that formulation matters.

How Central Aortic Pressure Is Measured — And Why It’s Different From Standard BP

Standard office blood pressure measures brachial artery pressure — convenient, but indirect. Because pressure waves travel faster in stiff arteries, they reflect back from branch points (like the abdominal aorta or carotid bifurcation) and augment pressure near the heart during systole. This “wave reflection” means central aortic systolic pressure can be 10–20 mm Hg higher than brachial pressure — even when the cuff reading looks fine.

Tonometric central BP assessment uses a high-fidelity pressure sensor gently pressed against the radial artery (wrist). Software then generates a central aortic waveform via validated transfer function. While not yet routine in primary care, it’s increasingly used in hypertension specialty clinics and clinical trials — especially for patients with isolated systolic hypertension, diabetes, or chronic kidney disease.

Key metrics include:

• Central aortic systolic pressure (CASP): ideal target <120 mm Hg
• Augmentation index (AIx): % of central pulse pressure due to reflected waves; >25% suggests excessive wave reflection
• Pulse wave velocity (PWV): gold-standard measure of arterial stiffness; normal <8 m/s, high ≥10 m/s

Unlike home BP cuffs, tonometry requires trained technicians and specialized equipment — so it’s not something you’ll do yourself. But knowing your PWV (often assessed during cardiac CT or echo labs) or AIx (available in some advanced BP devices) gives valuable context about how your arteries are aging.

Who Should Pay Special Attention to Magnesium Glycinate Central Aortic Pressure?

Three groups stand to gain the most insight from understanding magnesium glycinate central aortic pressure:

1. Adults 60+ with isolated systolic hypertension (e.g., 152/72 mm Hg): Elevated top number + low bottom number often reflects stiff arteries — exactly where magnesium glycinate showed strongest CASP-lowering effects in MAG-CAP.

2. People with conditions linked to magnesium depletion, such as type 2 diabetes (up to 30% have subclinical deficiency), chronic kidney disease (stages 3–4), or long-term use of proton-pump inhibitors (PPIs) or diuretics like furosemide.

3. Those with “white-coat” or masked hypertension: If home arm BP readings vary widely — or feel disconnected from symptoms like fatigue or lightheadedness — central pressure evaluation may reveal hidden strain.

Note: MAG-CAP excluded participants with heart failure (NYHA Class III/IV), severe renal impairment (eGFR <30 mL/min), or uncontrolled arrhythmias. So while promising, magnesium glycinate central aortic pressure benefits should be considered within individual clinical context — not as a standalone therapy.

Practical Steps You Can Take Today

Start with what’s within your control — and build from there.

Diet first: Aim for ~320 mg/day (women) or ~420 mg/day (men) of dietary magnesium from whole foods: spinach, almonds, black beans, avocado, and pumpkin seeds. One cup of cooked spinach provides ~157 mg; 1 oz almonds delivers ~80 mg. Supplements should complement — not replace — this foundation.

If considering supplementation: 200 mg elemental magnesium from glycinate is well-tolerated and aligns with MAG-CAP dosing. Avoid exceeding 350 mg/day from supplements unless directed by your clinician — higher doses may cause diarrhea or interact with certain medications (e.g., antibiotics, bisphosphonates).

Self-monitoring tips:

• Use an upper-arm, automated, oscillometric BP monitor validated for accuracy (look for ESH or AHA certification).
• Measure at the same time daily — ideally morning and evening — after 5 minutes of quiet rest, seated, feet flat, arm supported at heart level.
• Record both numbers, plus pulse rate and any symptoms (e.g., dizziness, palpitations).
• Note lifestyle factors: caffeine intake, sleep quality, stress level — all influence short-term BP variability.

Tracking your blood pressure trends can help you and your doctor make better decisions. Consider keeping a daily log or using a monitoring tool to stay informed.

When to see your doctor:

• Consistent brachial systolic BP ≥140 mm Hg or diastolic ≥90 mm Hg on multiple readings
• Sudden spikes (>20 mm Hg above your usual) accompanied by headache, chest tightness, or shortness of breath
• Dizziness or fainting when standing — could signal orthostatic hypotension or autonomic changes
• New or worsening leg swelling, fatigue, or irregular heartbeat

These signs warrant evaluation beyond routine BP checks — possibly including assessment of arterial stiffness or central pressure.

A Reassuring Note for Your Heart Health Journey

Blood pressure management isn’t about chasing a single number — it’s about supporting resilient arteries, steady circulation, and lifelong vitality. The MAG-CAP trial adds meaningful evidence that magnesium glycinate central aortic pressure benefits are real, measurable, and most helpful for those whose arteries need extra support. If you're unsure, talking to your doctor is always a good idea.

FAQ

#### Does magnesium glycinate lower central aortic pressure in older adults?

Yes — according to the 2024 MAG-CAP trial, adults aged 62+ with elevated pulse wave velocity who took 2,000 mg/day magnesium glycinate (≈200 mg elemental Mg) experienced a statistically significant average reduction of −3.7 mm Hg in central aortic systolic pressure after 24 weeks, with greater effects seen in those with the stiffest arteries.

#### How does magnesium glycinate central aortic pressure compare to other magnesium forms?

Magnesium glycinate demonstrated clinically meaningful reductions in central aortic pressure in MAG-CAP, whereas prior trials using magnesium oxide or citrate did not show consistent central BP benefits — likely due to differences in absorption, tolerability, and tissue targeting. Glycinate’s amino acid chelation enhances uptake and minimizes GI upset, making it especially suitable for older adults.

#### Can I measure magnesium glycinate central aortic pressure at home?

No — central aortic pressure requires specialized tonometric equipment (e.g., SphygmoCor or Arteriograph systems) and trained personnel. Home BP monitors measure brachial pressure only. However, some advanced upper-arm devices estimate central pressure indirectly — though these remain less accurate than clinical tonometry.

#### Is 2,000 mg of magnesium glycinate safe for seniors?

The 2,000 mg dose used in MAG-CAP refers to the compound, delivering ~200 mg of elemental magnesium — well within the Tolerable Upper Intake Level (UL) of 350 mg/day from supplements for adults. Always discuss new supplements with your healthcare provider, especially if you have kidney disease or take medications like anticoagulants or muscle relaxants.

#### What’s the difference between central aortic pressure and regular blood pressure?

Regular (brachial) blood pressure measures pressure in the arm artery; central aortic pressure estimates pressure in the ascending aorta — closer to the heart. Due to wave reflection in stiff arteries, central systolic pressure is often higher than brachial and better predicts cardiovascular risk, especially in older adults.